SCHEDULE: GRI Bio Stakeholders Report Ownership Update

GRI Bio, Inc. reports a beneficial ownership update from Intracoastal Capital LLC and associated individuals, holding just under 5% of the company's common stock.

Summary

• This filing is an amendment to a Schedule 13G, reporting a change in beneficial ownership of GRI Bio, Inc. common stock.
• The reporting persons are Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC.
• As of June 30, 2026, the reporting persons collectively beneficially owned 93,005 shares of common stock.
• This ownership represents approximately 4.99% of the outstanding common stock.
• The reported shares are primarily issuable upon the exercise of warrants held by Intracoastal Capital LLC.
• Certain shares issuable upon warrant exercise are excluded due to blocker provisions that limit beneficial ownership to 4.99%.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership percentage below the threshold that typically triggers significant market reaction.

Positives

• The reporting persons hold a significant stake, indicating investor interest in GRI Bio, Inc.
• The ownership is just below the 5% threshold, which may allow for future increases without immediate disclosure triggers.

Negatives

• The filing does not disclose any new capital investment or strategic initiatives by the reporting persons.
• The ownership is capped at 4.99% due to warrant blocker provisions, limiting immediate control or influence.

Risks

• The reliance on warrants for ownership means the actual number of shares held is contingent on warrant exercise.
• The blocker provisions on warrants limit the ability to increase ownership beyond 4.99% without triggering further disclosure requirements or potential dilution.

Future Outlook

The filing does not contain forward-looking statements or specific future guidance from the company. It solely reports on beneficial ownership.

Management Comments

• The reporting persons certify that the securities were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than in connection with a nomination under Rule 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual holders accumulating positions in public companies. The 4.99% ownership level is a typical point before a 5% threshold requires a more detailed Schedule 13D filing, suggesting a strategic approach to managing disclosure obligations.

Stakeholder Impact

• Shareholders: The filing provides transparency on a significant ownership block, which can influence market perception.
• Management: The reporting persons' certification indicates no immediate intent to influence control, providing some stability.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership levels.
• Further filings may be required if ownership exceeds 5% or if the nature of their investment changes to one seeking to influence control.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Warrants, Intracoastal Capital LLC, GRI Bio, SEC Filing, Ownership Threshold